Model-Based Quantification of the Systemic Interplay between Glucose and Fatty Acids in the Postprandial State

PLoS One. 2015 Sep 10;10(9):e0135665. doi: 10.1371/journal.pone.0135665. eCollection 2015.

Abstract

In metabolic diseases such as Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease, the systemic regulation of postprandial metabolite concentrations is disturbed. To understand this dysregulation, a quantitative and temporal understanding of systemic postprandial metabolite handling is needed. Of particular interest is the intertwined regulation of glucose and non-esterified fatty acids (NEFA), due to the association between disturbed NEFA metabolism and insulin resistance. However, postprandial glucose metabolism is characterized by a dynamic interplay of simultaneously responding regulatory mechanisms, which have proven difficult to measure directly. Therefore, we propose a mathematical modelling approach to untangle the systemic interplay between glucose and NEFA in the postprandial period. The developed model integrates data of both the perturbation of glucose metabolism by NEFA as measured under clamp conditions, and postprandial time-series of glucose, insulin, and NEFA. The model can describe independent data not used for fitting, and perturbations of NEFA metabolism result in an increased insulin, but not glucose, response, demonstrating that glucose homeostasis is maintained. Finally, the model is used to show that NEFA may mediate up to 30-45% of the postprandial increase in insulin-dependent glucose uptake at two hours after a glucose meal. In conclusion, the presented model can quantify the systemic interactions of glucose and NEFA in the postprandial state, and may therefore provide a new method to evaluate the disturbance of this interplay in metabolic disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Calibration
  • Computer Simulation
  • Databases as Topic
  • Fatty Acids / metabolism*
  • Fatty Acids, Nonesterified / metabolism
  • Glucose / metabolism*
  • Glucose Clamp Technique
  • Homeostasis
  • Humans
  • Insulin Infusion Systems
  • Kinetics
  • Models, Biological*
  • Postprandial Period*

Substances

  • Fatty Acids
  • Fatty Acids, Nonesterified
  • Glucose

Grants and funding

This study was supported by the European Union’s Seventh Programme for research, technological development and demonstration under grant agreement No 305707, the Linköping Initiative within Life Science Technologies, the Östergötland County Council, and the Swedish Research Council. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AstraZeneca provided support in the form of salary for author EN, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the ‘author contributions’ section.